These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33926904)

  • 1. CONSORT extension for the reporting of randomised controlled trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE): checklist with explanation and elaboration.
    Kwakkenbos L; Imran M; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ; 2021 Apr; 373():n857. PubMed ID: 33926904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a scoping review to support development of a CONSORT extension for randomised controlled trials using cohorts and routinely collected health data.
    Kwakkenbos L; Imran M; McCord KA; Sampson M; Fröbert O; Gale C; Hemkens LG; Langan SM; Moher D; Relton C; Zwarenstein M; Benchimol EI; Boutron I; Campbell MK; Erlinge D; Jawad S; Ravaud P; Rice DB; Sauve M; van Staa TP; Thabane L; Uher R; Verkooijen HM; Juszczak E; Thombs BD
    BMJ Open; 2018 Aug; 8(8):e025266. PubMed ID: 30082372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
    Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
    Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
    BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration (Traditional Chinese Version).
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):W7-W20. PubMed ID: 28654988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and Elaboration.
    Cheng CW; Wu TX; Shang HC; Li YP; Altman DG; Moher D; Bian ZX;
    Ann Intern Med; 2017 Jul; 167(2):112-121. PubMed ID: 28654980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting quality and adherence of randomized controlled trials about statins and/or fibrates for diabetic retinopathy to the CONSORT checklist.
    Mozetic V; Leonel L; Leite Pacheco R; de Oliveira Cruz Latorraca C; Guimarães T; Logullo P; Riera R
    Trials; 2019 Dec; 20(1):729. PubMed ID: 31842982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the reporting of pragmatic trials: an extension of the CONSORT statement.
    Zwarenstein M; Treweek S; Gagnier JJ; Altman DG; Tunis S; Haynes B; Oxman AD; Moher D; ;
    BMJ; 2008 Nov; 337():a2390. PubMed ID: 19001484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG
    BMJ; 2010 Mar; 340():c869. PubMed ID: 20332511
    [No Abstract]   [Full Text] [Related]  

  • 17. Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers.
    Moher D; Hopewell S; Schulz KF; Altman DG
    Trials; 2011 Apr; 12():98. PubMed ID: 21504615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
    Junqueira DR; Zorzela L; Golder S; Loke Y; Gagnier JJ; Julious SA; Li T; Mayo-Wilson E; Pham B; Phillips R; Santaguida P; Scherer RW; Gøtzsche PC; Moher D; Ioannidis JPA; Vohra S;
    J Clin Epidemiol; 2023 Jun; 158():149-165. PubMed ID: 37100738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.